1. Home
  2. HURC vs PMN Comparison

HURC vs PMN Comparison

Compare HURC & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hurco Companies Inc.

HURC

Hurco Companies Inc.

HOLD

Current Price

$22.52

Market Cap

143.0M

Sector

Industrials

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$14.86

Market Cap

136.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
PMN
Founded
1968
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.0M
136.2M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
HURC
PMN
Price
$22.52
$14.86
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
17.8K
145.0K
Earning Date
06-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$0.29
52 Week High
$23.75
$27.40

Technical Indicators

Market Signals
Indicator
HURC
PMN
Relative Strength Index (RSI) 58.29 56.15
Support Level $16.29 $12.89
Resistance Level $23.61 $16.97
Average True Range (ATR) 0.66 1.46
MACD 0.08 -0.01
Stochastic Oscillator 98.43 50.10

Price Performance

Historical Comparison
HURC
PMN

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: